Skip to ContentSkip to Navigation
About us Latest news News News articles

Chemotherapy-related cardiovascular morbidity in testicular cancer patients. Markers & mechanisms

09 May 2011

PhD ceremony: Ms. R. Altena, 14.45 uur, uur, Academiegebouw, Broerstraat 5, Groningen

Title: Chemotherapy-related cardiovascular morbidity in testicular cancer patients. Markers & mechanisms

Promotor(s): prof. J.A. Gietema, prof. E.G.E. de Vries

Faculty: Medical Sciences


Since the introduction of platinum-based chemotherapy regimens in the late 1970s, testicular cancer has become a highly curable malignancy with a 10-year survival rate of 80%. As a result of this favourable prognosis, in addition to a still increasing incidence rate, the population of successfully treated testicular cancer survivors is growing. Treatment-related complications, in particular cardiovascular diseases, are increasingly recognised in this population. The aim of this thesis was to search for early biomarkers of subclinical treatment-related damage in testicular cancer patients treated with cisplatin-based chemotherapy. Increases in biomarkers for vascular damage were found, as well as increased damage to the heart and blood vessels. Possible targets for mechanisms that contribute to endothelial damage due to chemotherapy were also found. These findings may lead to early diagnosis of cardiovascular diseases in testicular cancer survivors and may facilitate their treatment.


Last modified:13 March 2020 01.10 a.m.
View this page in: Nederlands

More news

  • 29 November 2023

    UMCG opent nieuwe faciliteit voor microbioomonderzoek 

    Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...

  • 28 November 2023

    Science: more exciting than showbiz

    Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...

  • 13 November 2023

    UMCG beantwoordt vragen patiënten met hulp van AI

    Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...